0001104659-17-031086.txt : 20170509
0001104659-17-031086.hdr.sgml : 20170509
20170509140127
ACCESSION NUMBER: 0001104659-17-031086
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170505
FILED AS OF DATE: 20170509
DATE AS OF CHANGE: 20170509
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nivalis Therapeutics, Inc.
CENTRAL INDEX KEY: 0001626199
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208969493
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-945-7700
MAIL ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: N30 Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20141121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TROHA JANICE
CENTRAL INDEX KEY: 0001068894
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37449
FILM NUMBER: 17825732
MAIL ADDRESS:
STREET 2: 6850 NORTH BROADWAY
CITY: DENVER
STATE: CO
ZIP: 80221
4
1
a4.xml
4
X0306
4
2017-05-05
0
0001626199
Nivalis Therapeutics, Inc.
NVLS
0001068894
TROHA JANICE
C/O NIVALIS THERAPEUTICS, INC.
PO BOX 18387
BOULDER
CO
80308
0
1
0
0
Exec Vice President / COO
Common Stock
2017-05-05
4
P
0
10000
2.34
A
10000
D
The price recorded in Column 4 represents the actual price for the full block purchase.
/s/ R. Michael Carruthers, Attorney-in-Fact
2017-05-09